Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on ...

An update from Staar Surgical ( ($STAA) ) is now available. On January 6, 2026, STAAR Surgical reported that preliminary voting results from a ...

OMAHA, NE - January 08, 2026 - PRESSADVANTAGE - Kugler Vision announced the publication of its new feature, “Dr. Lance ...

SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such as ...

Rising prevalence of cataract cases and increasing adoption of advanced intraocular lens technologies are driving growth in the intraocular lens market, while high costs of premium lenses and limited ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

Staar Surgical shareholders appear to reject Alcon's increased $1.6B buyout offer after Broadwood Partners leads opposition ...

An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...